Skip to content
Dose Brief
Menu
No. 12 here · Grade B+

REMEVi review

REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Visit REMEVi Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$219/mo (all doses, compounded)
Tirzepatide
$319/mo (all doses, compounded)
Coverage
All 50 states
Brand-name
Compounded only

Prices read from REMEVi's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 August 2026, and read on the provider's own site rather than taken on trust: we checked https://remevihealth.com/pricing on 2026-08-01 and this row reflects what that page says. The line we publish is $219/mo (all doses, compounded). There is no earlier reading of ours to compare it against yet.

The scorecard

REMEVi scored on our six Brief Score factors. See the methodology.

Price Stability78/100
Supply Reliability88/100
Transparency88/100
Access Breadth96/100
Clinical Oversight87/100
Track Record87/100

What we like

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
  • A daily oral semaglutide tablet is offered alongside the injection
  • Available in all 50 states and DC, with no minimum commitment and no cancellation fee

The caveats

  • The flat rate is one of the highest entry prices in this ranking; the cheaper $149 figure needs a full year
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

The brief

Best for: Spanish-speaking patients wanting bilingual, LegitScript-certified compounded GLP-1. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Ranked #12 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about REMEVi.

Closest here

The providers scoring nearest REMEVi — the realistic shortlist if you're weighing it.

Weighing REMEVi against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs REMEVi, and every provider that outranks it is listed on the REMEVi alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect REMEVi's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.

← Back to all rankings